chr9-100284478-A-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_014425.5(INVS):āc.1943A>Gā(p.Asn648Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,614,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014425.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INVS | NM_014425.5 | c.1943A>G | p.Asn648Ser | missense_variant | 13/17 | ENST00000262457.7 | NP_055240.2 | |
INVS | NM_001318381.2 | c.1655A>G | p.Asn552Ser | missense_variant | 14/18 | NP_001305310.1 | ||
INVS | NM_001318382.2 | c.965A>G | p.Asn322Ser | missense_variant | 13/17 | NP_001305311.1 | ||
INVS | NR_134606.2 | n.2141A>G | non_coding_transcript_exon_variant | 13/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INVS | ENST00000262457.7 | c.1943A>G | p.Asn648Ser | missense_variant | 13/17 | 1 | NM_014425.5 | ENSP00000262457.2 | ||
INVS | ENST00000262456.6 | c.1943A>G | p.Asn648Ser | missense_variant | 13/18 | 5 | ENSP00000262456.2 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000224 AC: 56AN: 250414Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135640
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461798Hom.: 0 Cov.: 31 AF XY: 0.0000591 AC XY: 43AN XY: 727204
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74516
ClinVar
Submissions by phenotype
INVS-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 10, 2024 | The INVS c.1943A>G variant is predicted to result in the amino acid substitution p.Asn648Ser. This variant was reported in an individual with juvenile nephronophthisis in compound heterozygous state with another missense variant of uncertain significance in this gene (Tang et al 2019. PubMed ID: 31131822). This variant is reported in 0.29% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 26, 2016 | - - |
Infantile nephronophthisis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Nephronophthisis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at